Anti-hyperglycemic and Anti-hyperlipidemic Effects of the Triterpenoid-Rich Fractions from Rubus coreanus and Rubus crataegifolius and Their Main Component, Niga-ichigoside $F_1$, in Streptozotocin-induced Diabetic Rats

  • Choi, Jong-Won (College of Pharmacy, Kyungsung University) ;
  • Yoo, Yeong-Min (Department of Pharmaceutical Engineering, Sangji University) ;
  • Kim, Min-Young (Department of Pharmaceutical Engineering, Sangji University) ;
  • Nam, Jung-Hwan (Highland Agriculture Institute, Rural Development Administration) ;
  • Nugroho, Agung (Department of Pharmaceutical Engineering, Sangji University) ;
  • Park, Hee-Juhn (Department of Pharmaceutical Engineering, Sangji University)
  • 발행 : 2008.12.31

초록

To find the antidiabetic activity of the tripterpenoid-rich fractions of Rubus coreanus (TRF-cor) and R. crataegifolius (TRF-cra) leaves or its main component niga-ichigoside $F_1$ (Niga-$F_1$), anti-hyperglycemic and antihyperlipidemic effects were investigated in the diabetic rat model induced by streptozotocin (STZ). Treatments of rats with 200 mg/kg of the TRF-cor, TRF-cra (each, p.o.) or 20 mg/kg of Niga-$F_1$ significantly inhibited the increase of blood glucose concentration about 44.8%, 28.7% or 20.6%, respectively, in the diabetic rats. In addition, treatments with those fractions inhibited the increase of serum concentrations of triglyceride, total cholesterol or LDL-cholesterol caused by STZ. The inhibitory rate on atherogenic index (AI) values of the TRFcor (200 mg/kg), TRF-cra (200 mg/kg) or Niga-$F_1$ (20 mg/kg)-treated groups were decreased about 55.7%, 36.3% or 22.6%, respectively, comparable to STZ-treated group. In the oral glucose tolerance test, treatment of TRF-cor or TRF-cra inhibited the increase of blood glucose concentration in the STZ-induced rats. Administration of 20 mg/kg of Niga-$F_1$ (p.o.) also exhibited similar effects with the effects of both TRFs at 200 mg/kg dose (p.o.). These results support that the triterpenoids, in particular Niga-$F_1$, are contributed to the antidiabetic effects of R. coreanus or R. crataegifolius.

키워드

참고문헌

  1. Choi, J., Lee, K.T., Ha, J., Yun, S.Y., Ko, C.D., Jung, H.J., and Park, H.J., Antinociceptive and anti-inflammatory effects of niga-ichigoside F1 and 23-hydroxytormentic acid obtained from Rubus coreanus. Biol. Pharm. Bull. 26, 1436-1441 (2003) https://doi.org/10.1248/bpb.26.1436
  2. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 24, 499- 502 (1972)
  3. McGowan, M.W., Artiss, J.D., Strandbergh, D.R., and Zak, B., A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 29, 538-542 (1983)
  4. Miller, N.E., The evidence for the anti-atherogenicity of high density lipoprotein in man. Lipid. 13, 914-919 (1978) https://doi.org/10.1007/BF02533850
  5. Moon, G.S., Constituents and uses of medicinal herbs. Ilweolseogak, Seoul, pp. 310-311 (1994)
  6. Nam, J.H., Jung, H.J., Choi, J., Lee, K.T., and Park, H.J., The antigastropathic and anti-rheumatic effect of niga-ichigoside F1 and 23-hydroxytormentic acid isolated from the unripe fruits of Rubus coreanus in a rat model. Biol. Pharm. Bull. 29, 967-970 (2006) https://doi.org/10.1248/bpb.29.967
  7. Nam, J.H., Jung. H.J., Choi, J.W., Kim, W.B., and Park, H.J., Comparison of triterpenoid contents of the four Rubus plants in Korea Using TLCDM. Kor. J. Pharmacogn. 38, 187-191 (2007)
  8. Noma A., Nezu-Nakayama, K., Kita, M., and Okabe, H., Simultaneous determination of serum cholesterol in high- and low-density lipoproteins with use of heparin, Ca2+, and an anion-exchange resin. Clin. Chem. 24, 1504-1508 (1978)
  9. Richmond, W., Use of cholesterol oxidase for assay of total and free cholesterol in serum by continuous flow analysis. Clin. Chem. 22, 1579-1588 (1976)
  10. Shirwaikar, A., Rajendran, K., and Barik, R., Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J. Ethnopharmacol. 107, 285-290 (2006) https://doi.org/10.1016/j.jep.2006.03.012
  11. Steinberg, D., Oxidative modification of LDL and atherogenesis. Circulation. 95, 1062-1071 (1997) https://doi.org/10.1161/01.CIR.95.4.1062